CervoMed Statistics
Total Valuation
CervoMed has a market cap or net worth of $79.19 million. The enterprise value is $43.95 million.
Important Dates
The last earnings date was Monday, May 12, 2025, before market open.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CervoMed has 8.70 million shares outstanding. The number of shares has increased by 113.68% in one year.
| Current Share Class | 8.70M |
| Shares Outstanding | 8.70M |
| Shares Change (YoY) | +113.68% |
| Shares Change (QoQ) | -0.05% |
| Owned by Insiders (%) | 33.38% |
| Owned by Institutions (%) | 17.55% |
| Float | 4.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.51 |
| Forward PS | 20.70 |
| PB Ratio | 2.29 |
| P/TBV Ratio | 2.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.78
| Current Ratio | 9.78 |
| Quick Ratio | 9.35 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -93.42% and return on invested capital (ROIC) is -65.47%.
| Return on Equity (ROE) | -93.42% |
| Return on Assets (ROA) | -56.19% |
| Return on Invested Capital (ROIC) | -65.47% |
| Return on Capital Employed (ROCE) | -60.45% |
| Revenue Per Employee | $620,548 |
| Profits Per Employee | -$1.24M |
| Employee Count | 15 |
| Asset Turnover | 0.40 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.10% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -63.10% |
| 50-Day Moving Average | 8.36 |
| 200-Day Moving Average | 9.21 |
| Relative Strength Index (RSI) | 50.44 |
| Average Volume (20 Days) | 447,393 |
Short Selling Information
The latest short interest is 903,858, so 10.39% of the outstanding shares have been sold short.
| Short Interest | 903,858 |
| Short Previous Month | 971,779 |
| Short % of Shares Out | 10.39% |
| Short % of Float | 18.32% |
| Short Ratio (days to cover) | 1.43 |
Income Statement
In the last 12 months, CervoMed had revenue of $9.31 million and -$18.67 million in losses. Loss per share was -$2.14.
| Revenue | 9.31M |
| Gross Profit | -9.49M |
| Operating Income | -20.94M |
| Pretax Income | -5.04M |
| Net Income | -18.67M |
| EBITDA | n/a |
| EBIT | -20.94M |
| Loss Per Share | -$2.14 |
Full Income StatementBalance Sheet
The company has $35.24 million in cash and n/a in debt, giving a net cash position of $35.24 million or $4.05 per share.
| Cash & Cash Equivalents | 35.24M |
| Total Debt | n/a |
| Net Cash | 35.24M |
| Net Cash Per Share | $4.05 |
| Equity (Book Value) | 34.63M |
| Book Value Per Share | 3.98 |
| Working Capital | 34.63M |
Full Balance SheetCash Flow
| Operating Cash Flow | -19.00M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is -101.95%, with operating and profit margins of -224.91% and -200.58%.
| Gross Margin | -101.95% |
| Operating Margin | -224.91% |
| Pretax Margin | -200.58% |
| Profit Margin | -200.58% |
| EBITDA Margin | n/a |
| EBIT Margin | -224.91% |
| FCF Margin | n/a |